Sustained measles transmission in 2026, driven by declining childhood vaccination coverage and multiple ongoing outbreaks, forms the core driver of trader sentiment on total U.S. cases by August 31. As of August 6, the CDC reported 2,465 confirmed cases for the year—already exceeding the full 2025 total—with 94% linked to outbreaks and 93% occurring in unvaccinated individuals. Recent weekly increments of 24–78 cases reflect persistent community spread, particularly in states such as Utah and Pennsylvania. Official surveillance updates from the CDC, alongside any shifts in state-level reporting or vaccination campaigns, represent the key near-term data releases that could influence case trajectories before the August 31 cutoff.
Riepilogo sperimentale generato dall'AI con riferimento ai dati di Polymarket. Questo non è un consiglio di trading e non ha alcun ruolo nella risoluzione di questo mercato. · AggiornatoCasi di morbillo negli Stati Uniti entro il 31 agosto?
Casi di morbillo negli Stati Uniti entro il 31 agosto?
NUOVO
31 ago 2026
2500+
98%
2550+
93%
2600+
86%
$7,637 Vol.
2500+
$418 Vol.
98%
2550+
$932 Vol.
93%
2600+
$3,344 Vol.
86%
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.Sustained measles transmission in 2026, driven by declining childhood vaccination coverage and multiple ongoing outbreaks, forms the core driver of trader sentiment on total U.S. cases by August 31. As of August 6, the CDC reported 2,465 confirmed cases for the year—already exceeding the full 2025 total—with 94% linked to outbreaks and 93% occurring in unvaccinated individuals. Recent weekly increments of 24–78 cases reflect persistent community spread, particularly in states such as Utah and Pennsylvania. Official surveillance updates from the CDC, alongside any shifts in state-level reporting or vaccination campaigns, represent the key near-term data releases that could influence case trajectories before the August 31 cutoff.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Mercato aperto: Jul 31, 2026, 10:25 AM ET
Volume
$7,637Data di fine
31 ago 2026Mercato aperto
Jul 31, 2026, 10:25 AM ETResolver
0x65070BE91...Esito proposto: Sì
Nessuna contestazione
Esito finale: Sì
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.Sustained measles transmission in 2026, driven by declining childhood vaccination coverage and multiple ongoing outbreaks, forms the core driver of trader sentiment on total U.S. cases by August 31. As of August 6, the CDC reported 2,465 confirmed cases for the year—already exceeding the full 2025 total—with 94% linked to outbreaks and 93% occurring in unvaccinated individuals. Recent weekly increments of 24–78 cases reflect persistent community spread, particularly in states such as Utah and Pennsylvania. Official surveillance updates from the CDC, alongside any shifts in state-level reporting or vaccination campaigns, represent the key near-term data releases that could influence case trajectories before the August 31 cutoff.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Volume
$7,637Data di fine
31 ago 2026Mercato aperto
Jul 31, 2026, 10:25 AM ETResolver
0x65070BE91...Esito proposto: Sì
Nessuna contestazione
Esito finale: Sì
Sustained measles transmission in 2026, driven by declining childhood vaccination coverage and multiple ongoing outbreaks, forms the core driver of trader sentiment on total U.S. cases by August 31. As of August 6, the CDC reported 2,465 confirmed cases for the year—already exceeding the full 2025 total—with 94% linked to outbreaks and 93% occurring in unvaccinated individuals. Recent weekly increments of 24–78 cases reflect persistent community spread, particularly in states such as Utah and Pennsylvania. Official surveillance updates from the CDC, alongside any shifts in state-level reporting or vaccination campaigns, represent the key near-term data releases that could influence case trajectories before the August 31 cutoff.
Riepilogo sperimentale generato dall'AI con riferimento ai dati di Polymarket. Questo non è un consiglio di trading e non ha alcun ruolo nella risoluzione di questo mercato. · Aggiornato
Fai attenzione ai link esterni.
Fai attenzione ai link esterni.
Domande frequenti